[Evidence-based drug therapy for male infertility]

Area of Science:

• Reproductive Medicine
• Andrology
• Pharmacology

Context:

• Male infertility affects a significant portion of the population, with idiopathic cases and those requiring surgery posing challenges.
• Current drug therapies for male infertility are often empirical and lack robust evidence-based medicine standards.
• Lack of uniform statistical endpoints in studies hinders treatment evaluation.

Purpose:

• To review current drug therapy options for male infertility based on literature and guidelines.
• To highlight the limitations of existing scientific data for drug treatments and dietary supplements.
• To emphasize the need for critical indications for drug therapy, considering side effects and costs.

Summary:

• Idiopathic male infertility and cases needing surgery represent 60% of diagnoses, complicating targeted drug treatment.
• Many male infertility drug studies lack rigorous methodology (randomized, placebo-controlled) and consistent outcome measures.
• Insufficient scientific data necessitates careful consideration of risks, costs, and potential benefits of current therapies.

Impact:

• Highlights the need for higher quality research in male infertility pharmacotherapy.
• Suggests reproductive medicine approaches may be more promising when drug therapy is insufficient.
• Underscores the importance of evidence-based practice and critical evaluation of treatment options for male infertility.